Cargando…

Treatment‐related experiences and preferences of patients with lung cancer: a qualitative analysis

BACKGROUND: Lung cancer is one of the most common types of cancer worldwide, and it causes significant challenges for patients due to the poor survival rate and treatment‐related side‐effects. Because of lung cancer's great burden, identification and use of the patients' preferences can he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aumann, Ines, Kreis, Kristine, Damm, Kathrin, Golpon, Heiko, Welte, Tobias, Graf von der Schulenburg, J. Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139048/ https://www.ncbi.nlm.nih.gov/pubmed/26468689 http://dx.doi.org/10.1111/hex.12417

Ejemplares similares

Therapy preferences of patients with lung and colon cancer: a discrete choice experiment
por: Schmidt, Katharina, et al.
Publicado: (2017)

Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis
por: Aumann, I., et al.
Publicado: (2016)

Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting
por: Schmidt, Katharina, et al.
Publicado: (2015)

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
por: Lange, Ansgar, et al.
Publicado: (2014)

Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting
por: Treskova, Marina, et al.
Publicado: (2017)

Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review
por: Babac, Ana, et al.
Publicado: (2019)

Integrating patient perspectives in medical decision-making: a qualitative interview study examining potentials within the rare disease information exchange process in practice
por: Babac, Ana, et al.
Publicado: (2019)

Preferences of patients with asthma or COPD for treatments in pulmonary rehabilitation
por: Damm, Kathrin, et al.
Publicado: (2021)

Patient- and person-reports on healthcare: preferences, outcomes, experiences, and satisfaction – an essay
por: Klose, K., et al.
Publicado: (2016)

Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseases
por: Pauer, Frédéric, et al.
Publicado: (2016)

Promoting vaccinations - an analysis of measures taken by German statutory health insurers
por: Damm, Kathrin, et al.
Publicado: (2011)

Shaping an Effective Health Information Website on Rare Diseases Using a Group Decision-Making Tool: Inclusion of the Perspectives of Patients, Their Family Members, and Physicians
por: Babac, Ana, et al.
Publicado: (2017)

Use and importance of different information sources among patients with rare diseases and their relatives over time: a qualitative study
por: Litzkendorf, Svenja, et al.
Publicado: (2020)

Age- and gender-based comorbidity categories in general practitioner and pulmonology patients with COPD
por: Kim-Dorner, Su-Jong, et al.
Publicado: (2022)

Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks
por: Schmidt, Katharina, et al.
Publicado: (2016)

Potential Roles of Acute Phase Proteins in Cancer: Why Do Cancer Cells Produce or Take Up Exogenous Acute Phase Protein Alpha1-Antitrypsin?
por: Janciauskiene, Sabina, et al.
Publicado: (2021)

Dividend policy issues in the European pharmaceutical industry: new empirical evidence
por: Basse, Tobias, et al.
Publicado: (2022)

COVID-19: not the time for health economists? A plea for more proactive health economic involvement
por: Schulenburg, J.-Matthias Graf von der
Publicado: (2021)

Greetings from the Editors
por: Graf von der Schulenburg, J-Matthias, et al.
Publicado: (2011)

Benefit assessment in Germany: implications for price discounts
por: Theidel, Ulrike, et al.
Publicado: (2016)

Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension
por: Nickel, Nils P, et al.
Publicado: (2013)

Are there social gradients in the occurrence of lung cancer and in the survival of lung cancer patients? Findings from an observational study using German claims data of Lower Saxony
por: Schröder, Sebastian, et al.
Publicado: (2020)

The German plan for rare diseases: a development in progress
por: Graf von der Schulenburg, Johann Mathias
Publicado: (2010)

Regional differences of outpatient physician supply as a theoretical economic and empirical generalized linear model
por: Scholz, Stefan, et al.
Publicado: (2015)

German Value Set for the EQ-5D-5L
por: Ludwig, Kristina, et al.
Publicado: (2018)

Valuation of the EQ-5D-5L with composite time trade-off for the German population – an exploratory study
por: Ludwig, Kristina, et al.
Publicado: (2017)

Note from the editor, January 2021
por: von der Schulenburg, J.-Matthias Graf, et al.
Publicado: (2021)

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany
por: Babac, Ana, et al.
Publicado: (2018)

Compression, expansion, or maybe both? Growing inequalities in lung cancer in Germany
por: Tetzlaff, Fabian, et al.
Publicado: (2020)

Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency
por: Koczulla, A-Rembert, et al.
Publicado: (2012)

Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system
por: Kuhlmann, Alexander, et al.
Publicado: (2013)

Genome sequencing: a systematic review of health economic evidence
por: Frank, Martin, et al.
Publicado: (2013)

The Role of decision-analytic modelling in German health technology assessments
por: Kuhlmann, Alexander, et al.
Publicado: (2015)

Socioeconomic inequalities in lung cancer – a time trend analysis with German health insurance data
por: Tetzlaff, Fabian, et al.
Publicado: (2021)

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
por: Kuhlmann, Alexander, et al.
Publicado: (2012)

Nachhaltige Vergütung der B‑Zentren für Seltene Erkrankungen in Deutschland – Status quo und Lösungsansätze
por: Litzkendorf, Svenja, et al.
Publicado: (2022)

Calcineurin-inhibitor free immunosuppression after lung transplantation – a single center case-control study in 51 patients converted to Mechanistic Target of Rapamycin (mTOR) inhibitors
por: Gottlieb, Jens, et al.
Publicado: (2023)

Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study
por: Litzkendorf, Svenja, et al.
Publicado: (2018)

Patient preferences in allergy immunotherapy (AIT) in Germany – a discrete-choice-experiment
por: Damm, Kathrin, et al.
Publicado: (2016)

Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -
por: Klora, Mike, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f3d7jiifu40dl8ltgvstlo1ku2